Multi-Manager Framework: Greenwald + Dalio + Soros + Druckenmiller + Laffont + Ackman + Cohen/Griffin
Generated: 2026-07-21 03:57:09 · EDGAR + yfinance
BAMXF trades at 0% premium to EPV, the market is pricing in significant growth. Grade C quality (EQ 4/10). Growth is justified IF ROIC stays above WACC, spread is 0.7%.
Neutral setup, no strong reflexivity signal. Limited catalysts visible. Monitor for Stage 2 entry signal. Patience is a position.
| Ticker | Rationale | Mkt Cap | EV/EBITDA TTM | EV/EBIT TTM | EV/Rev TTM | EV/FCF TTM | Fwd P/E FWD | EBITDA Mg TTM | Rev Gr. YoY | ND/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|
| AAPL ✓ | Benchmark: Apple, $3T market cap proxy for br | $4.8T | 37.2x | N/A | 12.5x | 47.7x | 33.9x | +34% | +3% | 0.7x |
| MSFT ✓ | Benchmark: Microsoft, diversified tech; cloud | $3.0T | 28.3x | N/A | 14.1x | 47.7x | 20.8x | +50% | +14% | 0.4x |
| JNJ ✓ | Benchmark: J&J, diversified healthcare; defen | $599B | 23.4x | N/A | 7.7x | 34.5x | 19.4x | +33% | +5% | 1.5x |
| PG ✓ | Benchmark: Procter & Gamble, consumer staples | $347B | 18.0x | N/A | 4.7x | 26.1x | 21.1x | +26% | +3% | 1.2x |
| JPM ✓ | Benchmark: JPMorgan, financials baseline; eco | $901B | N/A | N/A | 14.5x | N/A | 13.7x | N/A | +11% | N/A |
| Peer Median | N/A | 25.9x | N/A | 12.5x | 41.1x | 20.8x | +33% | N/A | 0.9x | |
| Subject Company | N/A | 9.1x | N/A | 1.0x | 56.8x | 4.4x | +11% | N/A | 6.4x | |
| Base EBIT (Operating Income) TTM | $10.0B |
| Line 5: D&A Adj. (Under-depreciation charge) | $2.3B |
| Adjusted EBIT | $7.7B |
| Quality Haircut (earnings-quality grade) | -10% |
| × (1 − Tax Rate) (27.2% actual ETR) | $5.1B |
| Sustainable NOPAT ÷ WACC (7.3%) | $68.9B |
|
Santos/Greenwald Enhancements
ROIC 2.7% (No franchise)
| |
| 1 | Base EBIT (Operating Income) | $10.0B | From income statement |
| 2 | D&A Adjustment (Greenwald Line 5) | $2.3B | Over/underdepreciation vs maintenance CapEx |
| 3 | = Adjusted EBIT | $7.7B | |
| 4 | Quality Haircut (10%) | -10% | Based on earnings quality grade |
| 5 | x (1 - Tax Rate) | 27.2% actual ETR | |
| = | Sustainable NOPAT | $5.1B | Net Operating Profit After Tax |
| / | WACC (7.3%) | Weighted average cost of capital | |
| = | EPV Operating | $68.9B | Enterprise value on no-growth basis |
| + | Cash | +$18.9B | |
| - | Total Debt | -$112.2B | |
| = | EPV of Equity | $-24.4B | |
| / | Shares Outstanding | 600M | |
| = | EPV Per Share | $0 | vs. Market Price $66.30 |
| Ticker | Rationale | Mkt Cap | EV/EBITDA TTM | EV/EBIT TTM | EV/Rev TTM | EV/FCF TTM | Fwd P/E FWD | EBITDA Mg TTM | Rev Gr. YoY | ND/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|
| AAPL ✓ | Benchmark: Apple, $3T market cap proxy for br | $4.8T | 37.2x | N/A | 12.5x | 47.7x | 33.9x | +34% | +3% | 0.7x |
| MSFT ✓ | Benchmark: Microsoft, diversified tech; cloud | $3.0T | 28.3x | N/A | 14.1x | 47.7x | 20.8x | +50% | +14% | 0.4x |
| JNJ ✓ | Benchmark: J&J, diversified healthcare; defen | $599B | 23.4x | N/A | 7.7x | 34.5x | 19.4x | +33% | +5% | 1.5x |
| PG ✓ | Benchmark: Procter & Gamble, consumer staples | $347B | 18.0x | N/A | 4.7x | 26.1x | 21.1x | +26% | +3% | 1.2x |
| JPM ✓ | Benchmark: JPMorgan, financials baseline; eco | $901B | N/A | N/A | 14.5x | N/A | 13.7x | N/A | +11% | N/A |
| Peer Median | N/A | 25.9x | N/A | 12.5x | 41.1x | 20.8x | +33% | N/A | 0.9x | |
| Subject Company | N/A | 9.1x | N/A | 1.0x | 56.8x | 4.4x | +11% | N/A | 6.4x | |
| Asset | Book | Haircut | Liquidation |
|---|---|---|---|
| Cash | $18.9B | 100% | $18.9B |
| Receivables | $53.7B | 85% | $45.7B |
| Inventory | $53.7B | 60% | $32.2B |
| PP&E | $92.9B | 50% | $46.5B |
| Other | $26.9B | 25% | $6.7B |
| Goodwill | $1.4B | 0% | N/A |
| Intangibles | $18.5B | 0% | N/A |